{
    "@context": "http://id.who.int/icd/contexts/contextForICD10Entity.json",
    "@id": "http://id.who.int/icd/release/10/2016/P93",
    "parent": [
        "http://id.who.int/icd/release/10/2016/P90-P96"
    ],
    "browserUrl": "http://apps.who.int/classifications/icd10/browse/2016/en#/P93",
    "code": "P93",
    "title": {
        "@language": "en",
        "@value": "Reactions and intoxications due to drugs administered to fetus and newborn"
    },
    "inclusion": [
        {
            "label": {
                "@language": "en",
                "@value": "Grey syndrome from chloramphenicol administration in newborn"
            }
        }
    ],
    "exclusion": [
        {
            "label": {
                "@language": "en",
                "@value": "jaundice due to drugs or toxins transmitted from mother or given to newborn"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "reactions and intoxications from maternal opiates, tranquillizers and other medication"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "withdrawal symptoms from: maternal use of drugs of addiction"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "withdrawal symptoms from: therapeutic use of drugs in newborn"
            }
        }
    ],
    "classKind": "category"
}